Skip to content

Effect of probiotic supplements on children's asthma

Evaluation of the therapeutic effect of adding probiotic oral powder to standard treatment for the improvement of mild to moderate asthma in children

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180115038378N1
Enrollment
120
Registered
2018-09-12
Start date
2018-06-15
Completion date
Unknown
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma. Asthma

Interventions

Intervention 1: Intervention group: Patients in this group consume 500 mg of Fmilact probiotics (produced by Zist Takhmir Company) for one month after three meals. Intervention 2: Control group: Patie

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 8 Years

Inclusion criteria

Inclusion criteria: All 3 to 8 years old children with mild to moderate asthma

Exclusion criteria

Exclusion criteria: Age under 3 and over 8 People with seasonal allergies Children with severe and persistent asthma

Design outcomes

Primary

MeasureTime frame
Control of asthma symptoms. Timepoint: The 30th day after starting intervention. Method of measurement: PRAM standard questionnaire.

Secondary

MeasureTime frame
Disruption to go to the school due to a severe cough. Timepoint: The 30th day after starting intervention. Method of measurement: PRAM standard questionnaire.;The frequency of asthma attacks. Timepoint: The 30th day after starting intervention. Method of measurement: PRAM standard questionnaire.;Use Nasal spray or Nebulizer. Timepoint: The 30th day after starting intervention. Method of measurement: PRAM standard questionnaire.;The frequency of waking up at night. Timepoint: The 30th day after starting intervention. Method of measurement: PRAM standard questionnaire.;Control of cough symptoms. Timepoint: The 30th day after starting intervention. Method of measurement: PRAM standard questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Homan Tehrani

Sabzevar University of Medical Sciences

tehranih911@mums.ac.ir+98 51 4401 1604

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026